Global Hematopoietic Stem Cell Transplantation (HSCT) Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 20-Sep-2022
No. of pages: 95
Inquire Before Buying

Report Scope

This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Hematopoietic Stem Cell Transplantation (HSCT) companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Hematopoietic Stem Cell Transplantation (HSCT) market. Further, it explains the major drivers and regional dynamics of the global Hematopoietic Stem Cell Transplantation (HSCT) market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- Regen Biopharma Inc

- China Cord Blood Corp

- CBR Systems Inc

- Escape Therapeutics Inc

- Cryo-Save AG

- Lonza Group Ltd

- Pluristem Therapeutics Inc

- ViaCord Inc

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Hematopoietic Stem Cell Transplantation (HSCT) Segment by Type

- Allogeneic

- Autologous

Hematopoietic Stem Cell Transplantation (HSCT) Segment by Application

- Peripheral Blood Stem Cells Transplant (PBSCT)

- Bone Marrow Transplant (BMT)

- Cord Blood Transplant (CBT)

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Hematopoietic Stem Cell Transplantation (HSCT) market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Hematopoietic Stem Cell Transplantation (HSCT) market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Hematopoietic Stem Cell Transplantation (HSCT), also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Hematopoietic Stem Cell Transplantation (HSCT), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Hematopoietic Stem Cell Transplantation (HSCT) revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Hematopoietic Stem Cell Transplantation (HSCT) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Hematopoietic Stem Cell Transplantation (HSCT) revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Regen Biopharma Inc, China Cord Blood Corp, CBR Systems Inc, Escape Therapeutics Inc, Cryo-Save AG, Lonza Group Ltd, Pluristem Therapeutics Inc and ViaCord Inc, etc.

Global Hematopoietic Stem Cell Transplantation (HSCT) Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hematopoietic Stem Cell Transplantation (HSCT) Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Allogeneic
1.2.3 Autologous
1.3 Market by Application
1.3.1 Global Hematopoietic Stem Cell Transplantation (HSCT) Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Peripheral Blood Stem Cells Transplant (PBSCT)
1.3.3 Bone Marrow Transplant (BMT)
1.3.4 Cord Blood Transplant (CBT)
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Hematopoietic Stem Cell Transplantation (HSCT) Market Size (2017-2028)
2.2 Hematopoietic Stem Cell Transplantation (HSCT) Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Hematopoietic Stem Cell Transplantation (HSCT) Market Size by Region (2017-2022)
2.4 Global Hematopoietic Stem Cell Transplantation (HSCT) Market Size Forecast by Region (2023-2028)
2.5 Global Top Hematopoietic Stem Cell Transplantation (HSCT) Countries Ranking by Market Size
3 Hematopoietic Stem Cell Transplantation (HSCT) Competitive by Company
3.1 Global Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Players
3.1.1 Global Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Players (2017-2022)
3.1.2 Global Hematopoietic Stem Cell Transplantation (HSCT) Market Share by Players (2017-2022)
3.2 Global Hematopoietic Stem Cell Transplantation (HSCT) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Hematopoietic Stem Cell Transplantation (HSCT) Revenue
3.4 Global Hematopoietic Stem Cell Transplantation (HSCT) Market Concentration Ratio
3.4.1 Global Hematopoietic Stem Cell Transplantation (HSCT) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hematopoietic Stem Cell Transplantation (HSCT) Revenue in 2021
3.5 Global Hematopoietic Stem Cell Transplantation (HSCT) Key Players Head office and Area Served
3.6 Key Players Hematopoietic Stem Cell Transplantation (HSCT) Product Solution and Service
3.7 Date of Enter into Hematopoietic Stem Cell Transplantation (HSCT) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Hematopoietic Stem Cell Transplantation (HSCT) Breakdown Data by Type
4.1 Global Hematopoietic Stem Cell Transplantation (HSCT) Historic Revenue by Type (2017-2022)
4.2 Global Hematopoietic Stem Cell Transplantation (HSCT) Forecasted Revenue by Type (2023-2028)
5 Global Hematopoietic Stem Cell Transplantation (HSCT) Breakdown Data by Application
5.1 Global Hematopoietic Stem Cell Transplantation (HSCT) Historic Market Size by Application (2017-2022)
5.2 Global Hematopoietic Stem Cell Transplantation (HSCT) Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Company (2020-2022)
6.2 North America Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Type (2017-2028)
6.3 North America Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Application (2017-2028)
6.4 North America Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Company (2020-2022)
7.2 Europe Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Type (2017-2028)
7.3 Europe Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Application (2017-2028)
7.4 Europe Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Company (2020-2022)
8.2 Asia Pacific Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Type (2017-2028)
8.3 Asia Pacific Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Application (2017-2028)
8.4 Asia Pacific Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 China Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
9 Latin America
9.1 Latin America Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Company (2020-2022)
9.2 Latin America Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Type (2017-2028)
9.3 Latin America Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Application (2017-2028)
9.4 Latin America Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Company (2020-2022)
10.2 Middle East and Africa Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Type (2017-2028)
10.3 Middle East and Africa Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Application (2017-2028)
10.4 Middle East and Africa Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Regen Biopharma Inc
11.1.1 Regen Biopharma Inc Company Details
11.1.2 Regen Biopharma Inc Business Overview
11.1.3 Regen Biopharma Inc Hematopoietic Stem Cell Transplantation (HSCT) Products and Services
11.1.4 Regen Biopharma Inc Hematopoietic Stem Cell Transplantation (HSCT) Revenue in Hematopoietic Stem Cell Transplantation (HSCT) Business (2017-2022)
11.1.5 Regen Biopharma Inc Hematopoietic Stem Cell Transplantation (HSCT) SWOT Analysis
11.1.6 Regen Biopharma Inc Recent Developments
11.2 China Cord Blood Corp
11.2.1 China Cord Blood Corp Company Details
11.2.2 China Cord Blood Corp Business Overview
11.2.3 China Cord Blood Corp Hematopoietic Stem Cell Transplantation (HSCT) Products and Services
11.2.4 China Cord Blood Corp Hematopoietic Stem Cell Transplantation (HSCT) Revenue in Hematopoietic Stem Cell Transplantation (HSCT) Business (2017-2022)
11.2.5 China Cord Blood Corp Hematopoietic Stem Cell Transplantation (HSCT) SWOT Analysis
11.2.6 China Cord Blood Corp Recent Developments
11.3 CBR Systems Inc
11.3.1 CBR Systems Inc Company Details
11.3.2 CBR Systems Inc Business Overview
11.3.3 CBR Systems Inc Hematopoietic Stem Cell Transplantation (HSCT) Products and Services
11.3.4 CBR Systems Inc Hematopoietic Stem Cell Transplantation (HSCT) Revenue in Hematopoietic Stem Cell Transplantation (HSCT) Business (2017-2022)
11.3.5 CBR Systems Inc Hematopoietic Stem Cell Transplantation (HSCT) SWOT Analysis
11.3.6 CBR Systems Inc Recent Developments
11.4 Escape Therapeutics Inc
11.4.1 Escape Therapeutics Inc Company Details
11.4.2 Escape Therapeutics Inc Business Overview
11.4.3 Escape Therapeutics Inc Hematopoietic Stem Cell Transplantation (HSCT) Products and Services
11.4.4 Escape Therapeutics Inc Hematopoietic Stem Cell Transplantation (HSCT) Revenue in Hematopoietic Stem Cell Transplantation (HSCT) Business (2017-2022)
11.4.5 Escape Therapeutics Inc Hematopoietic Stem Cell Transplantation (HSCT) SWOT Analysis
11.4.6 Escape Therapeutics Inc Recent Developments
11.5 Cryo-Save AG
11.5.1 Cryo-Save AG Company Details
11.5.2 Cryo-Save AG Business Overview
11.5.3 Cryo-Save AG Hematopoietic Stem Cell Transplantation (HSCT) Products and Services
11.5.4 Cryo-Save AG Hematopoietic Stem Cell Transplantation (HSCT) Revenue in Hematopoietic Stem Cell Transplantation (HSCT) Business (2017-2022)
11.5.5 Cryo-Save AG Hematopoietic Stem Cell Transplantation (HSCT) SWOT Analysis
11.5.6 Cryo-Save AG Recent Developments
11.6 Lonza Group Ltd
11.6.1 Lonza Group Ltd Company Details
11.6.2 Lonza Group Ltd Business Overview
11.6.3 Lonza Group Ltd Hematopoietic Stem Cell Transplantation (HSCT) Products and Services
11.6.4 Lonza Group Ltd Hematopoietic Stem Cell Transplantation (HSCT) Revenue in Hematopoietic Stem Cell Transplantation (HSCT) Business (2017-2022)
11.6.5 Lonza Group Ltd Hematopoietic Stem Cell Transplantation (HSCT) SWOT Analysis
11.6.6 Lonza Group Ltd Recent Developments
11.7 Pluristem Therapeutics Inc
11.7.1 Pluristem Therapeutics Inc Company Details
11.7.2 Pluristem Therapeutics Inc Business Overview
11.7.3 Pluristem Therapeutics Inc Hematopoietic Stem Cell Transplantation (HSCT) Products and Services
11.7.4 Pluristem Therapeutics Inc Hematopoietic Stem Cell Transplantation (HSCT) Revenue in Hematopoietic Stem Cell Transplantation (HSCT) Business (2017-2022)
11.7.5 Pluristem Therapeutics Inc Hematopoietic Stem Cell Transplantation (HSCT) SWOT Analysis
11.7.6 Pluristem Therapeutics Inc Recent Developments
11.8 ViaCord Inc
11.8.1 ViaCord Inc Company Details
11.8.2 ViaCord Inc Business Overview
11.8.3 ViaCord Inc Hematopoietic Stem Cell Transplantation (HSCT) Products and Services
11.8.4 ViaCord Inc Hematopoietic Stem Cell Transplantation (HSCT) Revenue in Hematopoietic Stem Cell Transplantation (HSCT) Business (2017-2022)
11.8.5 ViaCord Inc Hematopoietic Stem Cell Transplantation (HSCT) SWOT Analysis
11.8.6 ViaCord Inc Recent Developments
12 Hematopoietic Stem Cell Transplantation (HSCT) Market Dynamics
12.1 Hematopoietic Stem Cell Transplantation (HSCT) Market Trends
12.2 Hematopoietic Stem Cell Transplantation (HSCT) Market Drivers
12.3 Hematopoietic Stem Cell Transplantation (HSCT) Market Challenges
12.4 Hematopoietic Stem Cell Transplantation (HSCT) Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Tables
Table 1. Global Hematopoietic Stem Cell Transplantation (HSCT) Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Allogeneic
Table 3. Key Players of Autologous
Table 4. Global Hematopoietic Stem Cell Transplantation (HSCT) Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Hematopoietic Stem Cell Transplantation (HSCT) Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 6. Global Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Region (2017-2022) & (US$ Million)
Table 7. Global Hematopoietic Stem Cell Transplantation (HSCT) Revenue Market Share by Region (2017-2022)
Table 8. Global Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Players (2017-2022) & (US$ Million)
Table 9. Global Hematopoietic Stem Cell Transplantation (HSCT) Market Share by Players (2017-2022)
Table 10. Global Top Hematopoietic Stem Cell Transplantation (HSCT) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hematopoietic Stem Cell Transplantation (HSCT) as of 2021)
Table 11. Ranking of Global Top Hematopoietic Stem Cell Transplantation (HSCT) Companies by Revenue (US$ Million) in 2021
Table 12. Global 5 Largest Players Market Share by Hematopoietic Stem Cell Transplantation (HSCT) Revenue (CR5 and HHI) & (2017-2022)
Table 13. Key Players Headquarters and Area Served
Table 14. Key Players Hematopoietic Stem Cell Transplantation (HSCT) Product Solution and Service
Table 15. Date of Key Manufacturers Enter into Hematopoietic Stem Cell Transplantation (HSCT) Market
Table 16. Mergers & Acquisitions, Expansion Plans
Table 17. Global Hematopoietic Stem Cell Transplantation (HSCT) Market Size by Type (2017-2022) & (US$ Million)
Table 18. Global Hematopoietic Stem Cell Transplantation (HSCT) Revenue Market Share by Type (2017-2022)
Table 19. Global Hematopoietic Stem Cell Transplantation (HSCT) Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 20. Global Hematopoietic Stem Cell Transplantation (HSCT) Revenue Market Share by Type (2023-2028)
Table 21. Global Hematopoietic Stem Cell Transplantation (HSCT) Market Size by Application (2017-2022) & (US$ Million)
Table 22. Global Hematopoietic Stem Cell Transplantation (HSCT) Revenue Market Share by Application (2017-2022)
Table 23. Global Hematopoietic Stem Cell Transplantation (HSCT) Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 24. Global Hematopoietic Stem Cell Transplantation (HSCT) Revenue Market Share by Application (2023-2028)
Table 25. North America Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Company (2020-2022) & (US$ Million)
Table 26. North America Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Type (2017-2022) & (US$ Million)
Table 27. North America Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Type (2023-2028) & (US$ Million)
Table 28. North America Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Application (2017-2022) & (US$ Million)
Table 29. North America Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Application (2023-2028) & (US$ Million)
Table 30. North America Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Country (2017-2022) & (US$ Million)
Table 31. North America Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Country (2023-2028) & (US$ Million)
Table 32. Europe Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Company (2020-2022) & (US$ Million)
Table 33. Europe Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Type (2017-2022) & (US$ Million)
Table 34. Europe Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Type (2023-2028) & (US$ Million)
Table 35. Europe Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Application (2017-2022) & (US$ Million)
Table 36. Europe Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Application (2023-2028) & (US$ Million)
Table 37. Europe Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Country (2017-2022) & (US$ Million)
Table 38. Europe Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Country (2023-2028) & (US$ Million)
Table 39. Asia Pacific Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Company (2020-2022) & (US$ Million)
Table 40. Asia Pacific Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Type (2017-2022) & (US$ Million)
Table 41. Asia Pacific Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Type (2023-2028) & (US$ Million)
Table 42. Asia Pacific Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Application (2017-2022) & (US$ Million)
Table 43. Asia Pacific Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Application (2023-2028) & (US$ Million)
Table 44. Asia Pacific Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Region (2017-2022) & (US$ Million)
Table 45. Asia Pacific Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Region (2023-2028) & (US$ Million)
Table 46. Latin America Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Company (2020-2022) & (US$ Million)
Table 47. Latin America Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Type (2017-2022) & (US$ Million)
Table 48. Latin America Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Type (2023-2028) & (US$ Million)
Table 49. Latin America Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Application (2017-2022) & (US$ Million)
Table 50. Latin America Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Application (2023-2028) & (US$ Million)
Table 51. Latin America Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Country (2017-2022) & (US$ Million)
Table 52. Latin America Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Country (2023-2028) & (US$ Million)
Table 53. Middle East and Africa Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Company (2020-2022) & (US$ Million)
Table 54. Middle East and Africa Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Type (2017-2022) & (US$ Million)
Table 55. Middle East and Africa Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Type (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Application (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Application (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Country (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Hematopoietic Stem Cell Transplantation (HSCT) Revenue by Country (2023-2028) & (US$ Million)
Table 60. Regen Biopharma Inc Company Details
Table 61. Regen Biopharma Inc Business Overview
Table 62. Regen Biopharma Inc Hematopoietic Stem Cell Transplantation (HSCT) Product and Services
Table 63. Regen Biopharma Inc Hematopoietic Stem Cell Transplantation (HSCT) Revenue in Hematopoietic Stem Cell Transplantation (HSCT) Business (2017-2022) & (US$ Million)
Table 64. Regen Biopharma Inc Hematopoietic Stem Cell Transplantation (HSCT) SWOT Analysis
Table 65. Regen Biopharma Inc Recent Developments
Table 66. China Cord Blood Corp Company Details
Table 67. China Cord Blood Corp Business Overview
Table 68. China Cord Blood Corp Hematopoietic Stem Cell Transplantation (HSCT) Product and Services
Table 69. China Cord Blood Corp Hematopoietic Stem Cell Transplantation (HSCT) Revenue in Hematopoietic Stem Cell Transplantation (HSCT) Business (2017-2022) & (US$ Million)
Table 70. China Cord Blood Corp Hematopoietic Stem Cell Transplantation (HSCT) SWOT Analysis
Table 71. China Cord Blood Corp Recent Developments
Table 72. CBR Systems Inc Company Details
Table 73. CBR Systems Inc Business Overview
Table 74. CBR Systems Inc Hematopoietic Stem Cell Transplantation (HSCT) Product and Services
Table 75. CBR Systems Inc Hematopoietic Stem Cell Transplantation (HSCT) Revenue in Hematopoietic Stem Cell Transplantation (HSCT) Business (2017-2022) & (US$ Million)
Table 76. CBR Systems Inc Hematopoietic Stem Cell Transplantation (HSCT) SWOT Analysis
Table 77. CBR Systems Inc Recent Developments
Table 78. Escape Therapeutics Inc Company Details
Table 79. Escape Therapeutics Inc Business Overview
Table 80. Escape Therapeutics Inc Hematopoietic Stem Cell Transplantation (HSCT) Product and Services
Table 81. Escape Therapeutics Inc Hematopoietic Stem Cell Transplantation (HSCT) Revenue in Hematopoietic Stem Cell Transplantation (HSCT) Business (2017-2022) & (US$ Million)
Table 82. Escape Therapeutics Inc Hematopoietic Stem Cell Transplantation (HSCT) SWOT Analysis
Table 83. Escape Therapeutics Inc Recent Developments
Table 84. Cryo-Save AG Company Details
Table 85. Cryo-Save AG Business Overview
Table 86. Cryo-Save AG Hematopoietic Stem Cell Transplantation (HSCT) Product and Services
Table 87. Cryo-Save AG Hematopoietic Stem Cell Transplantation (HSCT) Revenue in Hematopoietic Stem Cell Transplantation (HSCT) Business (2017-2022) & (US$ Million)
Table 88. Cryo-Save AG Hematopoietic Stem Cell Transplantation (HSCT) SWOT Analysis
Table 89. Cryo-Save AG Recent Developments
Table 90. Lonza Group Ltd Company Details
Table 91. Lonza Group Ltd Business Overview
Table 92. Lonza Group Ltd Hematopoietic Stem Cell Transplantation (HSCT) Product and Services
Table 93. Lonza Group Ltd Hematopoietic Stem Cell Transplantation (HSCT) Revenue in Hematopoietic Stem Cell Transplantation (HSCT) Business (2017-2022) & (US$ Million)
Table 94. Lonza Group Ltd Hematopoietic Stem Cell Transplantation (HSCT) SWOT Analysis
Table 95. Lonza Group Ltd Recent Developments
Table 96. Pluristem Therapeutics Inc Company Details
Table 97. Pluristem Therapeutics Inc Business Overview
Table 98. Pluristem Therapeutics Inc Hematopoietic Stem Cell Transplantation (HSCT) Product and Services
Table 99. Pluristem Therapeutics Inc Hematopoietic Stem Cell Transplantation (HSCT) Revenue in Hematopoietic Stem Cell Transplantation (HSCT) Business (2017-2022) & (US$ Million)
Table 100. Pluristem Therapeutics Inc Hematopoietic Stem Cell Transplantation (HSCT) SWOT Analysis
Table 101. Pluristem Therapeutics Inc Recent Developments
Table 102. ViaCord Inc Company Details
Table 103. ViaCord Inc Business Overview
Table 104. ViaCord Inc Hematopoietic Stem Cell Transplantation (HSCT) Product and Services
Table 105. ViaCord Inc Hematopoietic Stem Cell Transplantation (HSCT) Revenue in Hematopoietic Stem Cell Transplantation (HSCT) Business (2017-2022) & (US$ Million)
Table 106. ViaCord Inc Hematopoietic Stem Cell Transplantation (HSCT) SWOT Analysis
Table 107. ViaCord Inc Recent Developments
Table 108. Hematopoietic Stem Cell Transplantation (HSCT) Market Trends
Table 109. Hematopoietic Stem Cell Transplantation (HSCT) Market Drivers
Table 110. Hematopoietic Stem Cell Transplantation (HSCT) Market Challenges
Table 111. Hematopoietic Stem Cell Transplantation (HSCT) Market Restraints
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hematopoietic Stem Cell Transplantation (HSCT) Sales Market Share by Type: 2021 VS 2028
Figure 2. Allogeneic Features
Figure 3. Autologous Features
Figure 4. Global Hematopoietic Stem Cell Transplantation (HSCT) Sales Market Share by Application: 2021 VS 2028
Figure 5. Peripheral Blood Stem Cells Transplant (PBSCT) Case Studies
Figure 6. Bone Marrow Transplant (BMT) Case Studies
Figure 7. Cord Blood Transplant (CBT) Case Studies
Figure 8. Hematopoietic Stem Cell Transplantation (HSCT) Report Years Considered
Figure 9. Global Hematopoietic Stem Cell Transplantation (HSCT) Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Hematopoietic Stem Cell Transplantation (HSCT) Market Size 2017-2028 (US$ Million)
Figure 11. Global Hematopoietic Stem Cell Transplantation (HSCT) Market Size Market Share by Region: 2021 VS 2028
Figure 12. Global Hematopoietic Stem Cell Transplantation (HSCT) Revenue Market Share by Region in 2017 VS 2022
Figure 13. Global Top 10 Hematopoietic Stem Cell Transplantation (HSCT) Countries Ranking by Market Size (US$ Million) in 2021
Figure 14. Global Hematopoietic Stem Cell Transplantation (HSCT) Market Share by Players in 2021
Figure 15. Global Top Hematopoietic Stem Cell Transplantation (HSCT) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hematopoietic Stem Cell Transplantation (HSCT) as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Hematopoietic Stem Cell Transplantation (HSCT) Revenue in 2021
Figure 17. North America Hematopoietic Stem Cell Transplantation (HSCT) Revenue Market Share by Company in 2021
Figure 18. North America Hematopoietic Stem Cell Transplantation (HSCT) Revenue Market Share by Type (2017-2028)
Figure 19. North America Hematopoietic Stem Cell Transplantation (HSCT) Revenue Market Share by Application (2017-2028)
Figure 20. North America Hematopoietic Stem Cell Transplantation (HSCT) Revenue Share by Country (2017-2028)
Figure 21. U.S. Hematopoietic Stem Cell Transplantation (HSCT) Revenue (2017-2028) & (US$ Million)
Figure 22. Canada Hematopoietic Stem Cell Transplantation (HSCT) Revenue (2017-2028) & (US$ Million)
Figure 23. Europe Hematopoietic Stem Cell Transplantation (HSCT) Revenue Market Share by Company in 2021
Figure 24. Europe Hematopoietic Stem Cell Transplantation (HSCT) Revenue Market Share by Type (2017-2028)
Figure 25. Europe Hematopoietic Stem Cell Transplantation (HSCT) Revenue Market Share by Application (2017-2028)
Figure 26. Europe Hematopoietic Stem Cell Transplantation (HSCT) Revenue Share by Country (2017-2028)
Figure 27. Germany Hematopoietic Stem Cell Transplantation (HSCT) Revenue (2017-2028) & (US$ Million)
Figure 28. France Hematopoietic Stem Cell Transplantation (HSCT) Revenue (2017-2028) & (US$ Million)
Figure 29. U.K. Hematopoietic Stem Cell Transplantation (HSCT) Revenue (2017-2028) & (US$ Million)
Figure 30. Italy Hematopoietic Stem Cell Transplantation (HSCT) Revenue (2017-2028) & (US$ Million)
Figure 31. Russia Hematopoietic Stem Cell Transplantation (HSCT) Revenue (2017-2028) & (US$ Million)
Figure 32. Asia Pacific Hematopoietic Stem Cell Transplantation (HSCT) Revenue Market Share by Company in 2021
Figure 33. Asia Pacific Hematopoietic Stem Cell Transplantation (HSCT) Revenue Market Share by Type (2017-2028)
Figure 34. Asia Pacific Hematopoietic Stem Cell Transplantation (HSCT) Revenue Market Share by Application (2017-2028)
Figure 35. Asia Pacific Hematopoietic Stem Cell Transplantation (HSCT) Revenue Share by Region (2017-2028)
Figure 36. China Hematopoietic Stem Cell Transplantation (HSCT) Revenue (2017-2028) & (US$ Million)
Figure 37. Japan Hematopoietic Stem Cell Transplantation (HSCT) Revenue (2017-2028) & (US$ Million)
Figure 38. South Korea Hematopoietic Stem Cell Transplantation (HSCT) Revenue (2017-2028) & (US$ Million)
Figure 39. India Hematopoietic Stem Cell Transplantation (HSCT) Revenue (2017-2028) & (US$ Million)
Figure 40. Australia Hematopoietic Stem Cell Transplantation (HSCT) Revenue (2017-2028) & (US$ Million)
Figure 41. China Taiwan Hematopoietic Stem Cell Transplantation (HSCT) Revenue (2017-2028) & (US$ Million)
Figure 42. Indonesia Hematopoietic Stem Cell Transplantation (HSCT) Revenue (2017-2028) & (US$ Million)
Figure 43. Thailand Hematopoietic Stem Cell Transplantation (HSCT) Revenue (2017-2028) & (US$ Million)
Figure 44. Malaysia Hematopoietic Stem Cell Transplantation (HSCT) Revenue (2017-2028) & (US$ Million)
Figure 45. Latin America Hematopoietic Stem Cell Transplantation (HSCT) Revenue Market Share by Company in 2021
Figure 46. Latin America Hematopoietic Stem Cell Transplantation (HSCT) Revenue Market Share by Type (2017-2028)
Figure 47. Latin America Hematopoietic Stem Cell Transplantation (HSCT) Revenue Market Share by Application (2017-2028)
Figure 48. Latin America Hematopoietic Stem Cell Transplantation (HSCT) Revenue Share by Country (2017-2028)
Figure 49. Mexico Hematopoietic Stem Cell Transplantation (HSCT) Revenue (2017-2028) & (US$ Million)
Figure 50. Brazil Hematopoietic Stem Cell Transplantation (HSCT) Revenue (2017-2028) & (US$ Million)
Figure 51. Argentina Hematopoietic Stem Cell Transplantation (HSCT) Revenue (2017-2028) & (US$ Million)
Figure 52. Middle East and Africa Hematopoietic Stem Cell Transplantation (HSCT) Revenue Market Share by Company in 2021
Figure 53. Middle East and Africa Hematopoietic Stem Cell Transplantation (HSCT) Revenue Market Share by Type (2017-2028)
Figure 54. Middle East and Africa Hematopoietic Stem Cell Transplantation (HSCT) Revenue Market Share by Application (2017-2028)
Figure 55. Middle East and Africa Hematopoietic Stem Cell Transplantation (HSCT) Revenue Share by Country (2017-2028)
Figure 56. Turkey Hematopoietic Stem Cell Transplantation (HSCT) Revenue (2017-2028) & (US$ Million)
Figure 57. Saudi Arabia Hematopoietic Stem Cell Transplantation (HSCT) Revenue (2017-2028) & (US$ Million)
Figure 58. UAE Hematopoietic Stem Cell Transplantation (HSCT) Revenue (2017-2028) & (US$ Million)
Figure 59. Regen Biopharma Inc Revenue Growth Rate in Hematopoietic Stem Cell Transplantation (HSCT) Business (2017-2022)
Figure 60. China Cord Blood Corp Revenue Growth Rate in Hematopoietic Stem Cell Transplantation (HSCT) Business (2017-2022)
Figure 61. CBR Systems Inc Revenue Growth Rate in Hematopoietic Stem Cell Transplantation (HSCT) Business (2017-2022)
Figure 62. Escape Therapeutics Inc Revenue Growth Rate in Hematopoietic Stem Cell Transplantation (HSCT) Business (2017-2022)
Figure 63. Cryo-Save AG Revenue Growth Rate in Hematopoietic Stem Cell Transplantation (HSCT) Business (2017-2022)
Figure 64. Lonza Group Ltd Revenue Growth Rate in Hematopoietic Stem Cell Transplantation (HSCT) Business (2017-2022)
Figure 65. Pluristem Therapeutics Inc Revenue Growth Rate in Hematopoietic Stem Cell Transplantation (HSCT) Business (2017-2022)
Figure 66. ViaCord Inc Revenue Growth Rate in Hematopoietic Stem Cell Transplantation (HSCT) Business (2017-2022)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs